![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 401/12 | (2006.01) |
C07D 401/12 | (2013.01) | ||
C07D 403/12 | (2006.01) | ||
C07D 403/12 | (2013.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 37/00 | (2018.01) | ||
A61P 37/00 | (2006.01) | ||
A61P 29/00 | (2018.01) | ||
A61K 31/4439 | (2006.01) | ||
A61K 31/501 | (2006.01) |
(11) | Patento numeris | 3999499 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 20753523.8 |
Europos patento paraiškos padavimo data | 2020-07-14 | |
(97) | Europos patento paraiškos paskelbimo data | 2022-05-25 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2024-09-04 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2020/041876 |
Data | 2020-07-14 |
(87) | Numeris | WO 2021/011513 |
Data | 2021-01-21 |
(30) | Numeris | Data | Šalis |
201962874531 P | 2019-07-16 | US |
(72) |
MOSLIN, Ryan M. , US
WEINSTEIN, David S. , US
RAMAR, Thangeswaran , IN
ANDAPPAN MURUGAIAH SUBBAIAH, Murugaiah , IN
|
(73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
(54) | PRODRUGS IN THE MODULATION OF INTERLEUKIN |
PRODRUGS IN THE MODULATION OF INTERLEUKIN |